Hansen's Disease (Leprosy): Current and Future Pharmacotherapy and Treatment of Disease-Related Immunologic Reactions-Reference-Cited by-同舟云学术

Hansen's Disease (Leprosy): Current and Future Pharmacotherapy and Treatment of Disease-Related Immunologic Reactions

Published:2012-01 Issue:1 Volume:32 Page:27-37
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Legendre Davey P.¹,Muzny Christina A.²,Swiatlo Edwin³

Affiliation:

1. The Pharmacy Division; Health Management Associates; Jackson Mississippi

2. The Division of Infectious Diseases; University of Alabama at Birmingham; Birmingham Alabama

3. The Division of Infectious Diseases; University of Mississippi Medical Center; Jackson Mississippi

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/PHAR.1009/fullpdf

Reference74 articles.

1. Stanford University. History of leprosy http://www.stanford.edu/group/parasites/ParaSites2005/Leprosy/history.htm

2. Global leprosy situation, 2007;World Health Organization;Wkly Epidemiol Rec,2007

3. U.S. Department of Health and Human Services, Health Resources and Services Administration Registry report: a summary of Hansen's disease in the United States 2008 http://www.hrsa.gov/hansens/dataandstatistics.html

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Haemophagocytic lymphohistiocytosis secondary to disseminated histoplasmosis in a patient with leprosy;BMJ Case Reports;2024-09

2. A Case of Multibacillary Borderline Lepromatous Leprosy in the United States Treated With Alternative Therapy;Cureus;2024-08-06

3. Response to “multibacillary leprosy mimicking systemic lupus erythematosus: case report and literature review”;Archives of Dermatological Research;2024-07-05

4. A Case of Lepromatous Leprosy (Lucio’s Phenomenon) Presenting as Periorbital Edema;Ophthalmic Plastic & Reconstructive Surgery;2024-05-09

5. Cutaneous Lupus Erythematosus: Review and Considerations for Older Populations;Drugs & Aging;2023-11-22